November 2, 2018

Around the nation: Top HHS drug pricing adviser dies

Daily Briefing

    CMS Administrator Seema Verma, in remarks on the  death of adviser Dan Best, said Best's passing "a loss to our country and to all of us personally who had the great privilege of working with Dan," in today's bite-sized hospital and health industry news from New Jersey, New York, and Washington, D.C.

    • New Jersey: State health officials on Thursday said that a 10th patient has died as a result of a viral outbreak at the Wanaque Center for Nursing and Rehabilitation. Officials said 27 cases of the adenovirus infection have been reported at the center (AP/Sacramento Bee, 11/1).

    • New York: Morgan Stanley has named David Stark its first CMO and head of its HR data and analytics. Stark previously served as an assistant professor at the Icahn School of Medicine at Mount Sinai. He was also the medical director at the Mount Sinai Institute for Next Generation Healthcare (Dietsche, MedCity News, 10/31).

    • Washington, D.C.: Dan Best, the top drug pricing adviser for HHS since April, has died, HHS Secretary Alex Azar said Thursday. Azar did not specify the cause of death. CMS Administrator Seema Verma said Best's death it "a loss to our country and to all of us personally who had the great privilege of working with Dan" (Swetlitz, STAT News, 11/1).

    Five ways to control the flow of drug expenditures

    Prescription drug expenditures are the fastest growing component of health care spending. And while reducing unwarranted prescribing variation is the single biggest improvement opportunity, there are several other near-term chances to reduce spending and grow revenues.

    Download Now

    X
    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.